We have just recently been made aware of the June 2017 NEJM article that found that Flublok is 30% more effective than the standard egg-grown flu vaccine for people aged 50-64.  What are other institutions doing?  Are you offering or recommending Flublok to this age group or relying on the egg-grown variety? We are aware that CDC does not have a preferential recommendation for one flu vaccine over another. Thanks for your thoughts and help!  Best, Tim

 

Tim Crump, MSN, FNP

Tim Crump, MSN, FNP

Family Nurse Practitioner

Multnomah Pavilion 1 SE, Suite 1110

Occupational Health

Healthcare Human Resources

 

Oregon Health & Science University

3181 SW Sam Jackson Park Rd

Mail code: UHN 89

Portland, OR 97239-3098

Department Phone: 503-494-5271

Office Phone: 503-346-1152

Fax: 503-494-4457

Email: crumpt@ohsu.edu

 

Mon-Fri, 7:30-4:00

 

cid:3381310330_334556

 

The information contained in this EMAIL message is confidential and protected by law. The information is intended only for the person or business identified in the document. If you are not the intended recipient, by sharing or copying the information you are breaking the law. If you have received this EMAIL by mistake, please notify the sender of this EMAIL and do not return, copy or keep the information in the EMAIL.